4//SEC Filing
Ondrey Aaron 4
Accession 0001140361-25-012826
CIK 0001281895other
Filed
Apr 7, 8:00 PM ET
Accepted
Apr 8, 4:06 PM ET
Size
4.8 KB
Accession
0001140361-25-012826
Insider Transaction Report
Form 4
Ondrey Aaron
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-04-04$5.29/sh−7,489$39,647→ 129,650 total
Footnotes (2)
- [F1]Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.
- [F2]The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.
Documents
Issuer
ROCKET PHARMACEUTICALS, INC.
CIK 0001281895
Entity typeother
Related Parties
1- filerCIK 0001991078
Filing Metadata
- Form type
- 4
- Filed
- Apr 7, 8:00 PM ET
- Accepted
- Apr 8, 4:06 PM ET
- Size
- 4.8 KB